{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:10:06Z","timestamp":1748254206040,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00063-025-01278-5","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T15:54:37Z","timestamp":1746633277000},"page":"438-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapie mit Blutprodukten auf der Intensivstation","Treatment with blood products in the intensive care unit"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-756X","authenticated-orcid":false,"given":"Sirak","family":"Petros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/00000542-200204000-00014","volume":"96","author":"RB Weiskopf","year":"2002","unstructured":"Weiskopf\u00a0RB, Feiner\u00a0J, Hopf\u00a0HW et\u00a0al (2002) Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 96:871\u2013877","journal-title":"Anesthesiology"},{"key":"1278_CR2","first-page":"681","volume":"82","author":"DR Spahn","year":"1996","unstructured":"Spahn\u00a0DR, Zollinger\u00a0A, Schlumpf\u00a0RB et\u00a0al (1996) Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 82:681\u2013686","journal-title":"Anesth Analg"},{"key":"1278_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM199902113400601","volume":"340","author":"PC Hebert","year":"1999","unstructured":"Hebert\u00a0PC, Wells\u00a0G, Blajchman\u00a0MA et\u00a0al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N\u00a0Engl J Med 340:409\u2013417","journal-title":"N Engl J Med"},{"key":"1278_CR4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMoa1406617","volume":"371","author":"LB Holst","year":"2014","unstructured":"Holst\u00a0LB, Haase\u00a0N, Wetterslev\u00a0J et\u00a0al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N\u00a0Engl J Med 371:1381\u20131391","journal-title":"N Engl J Med"},{"key":"1278_CR5","doi-asserted-by":"publisher","first-page":"e030854","DOI":"10.1136\/bmjopen-2019-030854","volume":"10","author":"RQ Yao","year":"2020","unstructured":"Yao\u00a0RQ, Ren\u00a0C, Zhang\u00a0ZC et\u00a0al (2020) Is haemoglobin below 7.0\u202fg\/dL an optimal trigger for allogenic red blood cell transfusion in patients admitted to intensive care units? A\u00a0meta-analysis and systematic review. Bmj Open 10:e30854","journal-title":"Bmj Open"},{"key":"1278_CR6","volume-title":"Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. In","author":"Bundes\u00e4rtekammer","year":"2020","unstructured":"Bundes\u00e4rtekammer (2020) Bundes\u00e4rtekammer. In: Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. In. Bundes\u00e4rztekammer, Berlin"},{"key":"1278_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0022-5223(94)70005-2","volume":"108","author":"DR Spahn","year":"1994","unstructured":"Spahn\u00a0DR, Smith\u00a0LR, Schell\u00a0RM et\u00a0al (1994) Importance of severity of coronary artery disease for the tolerance to normovolemic hemodilution. Comparison of single-vessel versus multivessel stenoses in a\u00a0canine model. J\u00a0Thorac Cardiovasc Surg 108:231\u2013239","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1278_CR8","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1056\/NEJMoa2307983","volume":"389","author":"JL Carson","year":"2023","unstructured":"Carson\u00a0JL, Brooks\u00a0MM, Hebert\u00a0PC et\u00a0al (2023) Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. N\u00a0Engl J Med 389:2446\u20132456","journal-title":"N Engl J Med"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S2468-1253(17)30054-7","volume":"2","author":"A Odutayo","year":"2017","unstructured":"Odutayo\u00a0A, Desborough\u00a0MJ, Trivella\u00a0M et\u00a0al (2017) Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a\u00a0systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol 2:354\u2013360","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1211801","volume":"368","author":"C Villanueva","year":"2013","unstructured":"Villanueva\u00a0C, Colomo\u00a0A, Bosch\u00a0A et\u00a0al (2013) Transfusion strategies for acute upper gastrointestinal bleeding. N\u00a0Engl J Med 368:11\u201321","journal-title":"N Engl J Med"},{"key":"1278_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","volume":"27","author":"R Rossaint","year":"2023","unstructured":"Rossaint\u00a0R, Afshari\u00a0A, Bouillon\u00a0B et\u00a0al (2023) The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care 27:80","journal-title":"Crit Care"},{"key":"1278_CR12","doi-asserted-by":"crossref","unstructured":"Slichter SJ (2007) Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program: 172\u2013178","DOI":"10.1182\/asheducation-2007.1.172"},{"key":"1278_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","volume":"18","author":"SJ Slichter","year":"2004","unstructured":"Slichter\u00a0SJ (2004) Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 18:153\u2013167","journal-title":"Transfus Med Rev"},{"key":"1278_CR14","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1111\/jth.15852","volume":"20","author":"T Iba","year":"2022","unstructured":"Iba\u00a0T, Levi\u00a0M, Levy\u00a0JH (2022) Intracellular communication and immunothrombosis in sepsis. J\u00a0Thromb Haemost 20:2475\u20132484","journal-title":"J Thromb Haemost"},{"key":"1278_CR15","first-page":"CD010984","volume":"2015","author":"LJ Estcourt","year":"2015","unstructured":"Estcourt\u00a0LJ, Stanworth\u00a0S, Doree\u00a0C et\u00a0al (2015) Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015:CD10984","journal-title":"Cochrane Database Syst Rev"},{"key":"1278_CR16","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1182\/blood.2022016558","volume":"140","author":"SJ Stanworth","year":"2022","unstructured":"Stanworth\u00a0SJ, Shah\u00a0A (2022) How I\u00a0use platelet transfusions. Blood 140:1925\u20131936","journal-title":"Blood"},{"key":"1278_CR17","doi-asserted-by":"publisher","first-page":"100031","DOI":"10.1016\/j.rpth.2022.100031","volume":"7","author":"J Hartmann","year":"2023","unstructured":"Hartmann\u00a0J, Hermelin\u00a0D, Levy\u00a0JH (2023) Viscoelastic testing: an illustrated review of technology and clinical applications. Res Pract Thromb Haemost 7:100031","journal-title":"Res Pract Thromb Haemost"},{"key":"1278_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5090\/jcs.23.081","volume":"57","author":"P Viana","year":"2024","unstructured":"Viana\u00a0P, Relvas\u00a0JH, Persson\u00a0M et\u00a0al (2024) Prothrombin Complex Concentrate versus Fresh Frozen Plasma in Adult Patients Undergoing Cardiac Surgery: A\u00a0Systematic Review and Meta-Analysis. J\u00a0Chest Surg 57:25\u201335","journal-title":"J Chest Surg"},{"key":"1278_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3324\/haematol.2014.123117","volume":"100","author":"D Zanolini","year":"2015","unstructured":"Zanolini\u00a0D, Merlin\u00a0S, Feola\u00a0M et\u00a0al (2015) Extrahepatic sources of factor\u00a0VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. Haematologica 100:881\u2013892","journal-title":"Haematologica"},{"key":"1278_CR20","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","volume":"128","author":"R Sarode","year":"2013","unstructured":"Sarode\u00a0R, Milling\u00a0TJ Jr., Refaai\u00a0MA et\u00a0al (2013) Efficacy and safety of a\u00a04-factor prothrombin complex concentrate in patients on vitamin\u00a0K antagonists presenting with major bleeding: a\u00a0randomized, plasma-controlled, phase\u00a0IIIb study. Circulation 128:1234\u20131243","journal-title":"Circulation"},{"key":"1278_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-023-04688-z","volume":"27","author":"I Hannadjas","year":"2023","unstructured":"Hannadjas\u00a0I, James\u00a0A, Davenport\u00a0R et\u00a0al (2023) Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses. Crit Care 27:422","journal-title":"Crit Care"},{"key":"1278_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","volume":"99","author":"DM Monroe","year":"1997","unstructured":"Monroe\u00a0DM, Hoffman\u00a0M, Oliver\u00a0JA et\u00a0al (1997) Platelet activity of high-dose factor\u00a0VIIa is independent of tissue factor. Br J Haematol 99:542\u2013547","journal-title":"Br J Haematol"},{"key":"1278_CR23","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/cc5026","volume":"10","author":"JL Vincent","year":"2006","unstructured":"Vincent\u00a0JL, Rossaint\u00a0R, Riou\u00a0B et\u00a0al (2006) Recommendations on the use of recombinant activated factor\u00a0VII as an adjunctive treatment for massive bleeding\u2014a European perspective. Crit Care 10:R120","journal-title":"Crit Care"},{"key":"1278_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","volume":"4","author":"J Kienast","year":"2006","unstructured":"Kienast\u00a0J, Juers\u00a0M, Wiedermann\u00a0CJ et\u00a0al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J\u00a0Thromb Haemost 4:90\u201397","journal-title":"J Thromb Haemost"},{"key":"1278_CR25","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans\u00a0L, Rhodes\u00a0A, Alhazzani\u00a0W et\u00a0al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49:e1063\u2013e1143","journal-title":"Crit Care Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-025-01278-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-025-01278-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-025-01278-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:44:35Z","timestamp":1748252675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-025-01278-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s00063-025-01278-5","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"type":"print","value":"2193-6218"},{"type":"electronic","value":"2193-6226"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"S.\u00a0Petros: A.\u00a0Finanzielle Interessen: Die Firma Werfen stellte kostenlos ein labordiagnostisches Ger\u00e4t f\u00fcr eine eigeninitiierte Studie zur Verf\u00fcgung. \u2013\u00a0Referentenhonorar von Firma CSL Behring.\u00a0\u2013 B. Nichtfinanzielle Interessen: Leiter, Interdisziplin\u00e4re Internistische Intensivmedizin, Universit\u00e4tsklinikum Leipzig; Leiter, Bereich H\u00e4mostaseologie, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Internistische Intensiv- und Notfallmedizin (DGIIN), Deutsche Interdisziplin\u00e4re Vereinigung f\u00fcr Intensiv- und Notfallmedizin (DIVI), European Society of Intensive Care Medicine, Gesellschaft f\u00fcr Thrombose und H\u00e4mostaseforschung (GTH).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}